Lisa Harding, MD

  • 3Articles
  • 18.6KReads1
  • 2018–2024Active
  • 16Collaborators
  • 13Citations2

About

Lisa Harding, MD, is affiliated with Yale University School of Medicine and Depression MD in Connecticut. Her publications from 2018 to 2024 focus on depression, including treatment-resistant depression, clinical approaches and algorithms, and specific clinical cases such as energy drink-induced manic episodes. She has collaborated frequently with colleagues including David C. Mohr and Eric J. Lenze. Her work appears in Psychiatrist.com, encompassing The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders.

Publications

JCP
Difficult to Treat Depression: Focus on Approach, Algorithms, and Access
Academic Highlights

Difficult to Treat Depression: Focus on Approach, Algorithms, and Access

November 25, 2024

The Southwest Forum on Difficult to Treat Depression brought together 11 experts to discuss aspects of managing difficult-to-treat depression. This article presents highlights from the forum, covering such topics...
, , , et al
JCP
Barriers to Esketamine Nasal Spray Use in Treatment-Resistant Depression
Original Research

Barriers to Esketamine Nasal Spray Use in Treatment-Resistant Depression

May 6, 2024

Potential barriers to treatment with esketamine nasal spray include travel distance, insurance, low socioeconomic status, and minority communities.
, , , et al
PCC
Letter to the Editor

Energy Drink-Induced Manic Episode in an Adolescent

November 15, 2018

Caffeine use has increased in the adolescent population due to energy drink consumption. Read this case of an adolescent patient who developed a manic episode after the withdrawal of...
, ,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe